Alert detail
FDA Approval: ABSORICA (ISOTRETINOIN) — Type 3 - New Dosage Form
Policy ID: FDA-NDA021951Specialty: DermatologyAdded: 6/17/2026Effective: 2012-05-25federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.